AVTR
Avantor, Inc.Price & Indicators
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $219.4M | Q1 2026 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 13.9% | Q1 2026 | — |
| Adjusted Operating Income non-GAAP | $190.6M | Q1 2026 | — |
| Adjusted Operating Income margin non-GAAP | 12.1% | Q1 2026 | — |
| Free cash flow non-GAAP | $25.2M | Q1 2026 | — |
|
|
|||
| free cash flow excluding restructuring costs non-GAAP | $39M | Q1 2026 call | — |
| Adjusted net leverage non-GAAP | 3.2 | as of December 31, 2025 | — |
| Organic sales decline non-GAAP | -2.8% | Full Year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AVTR
this stock
Avantor, Inc.
|
$7.13B | -8.3% | -7.3% | — | 6.5% |
|
ISRG
Intuitive Surgical Inc
|
$145.76B | -26.7% | +20.5% | 50.0 | 2.2% |
|
MDLN
Medline Inc.
|
$53.74B | -2.7% | +11.5% | — | 2.1% |
|
BDX
Becton Dickinson & Co
|
$41.57B | +0.0% | +8.2% | 57.3 | 2.6% |
|
ALC
Alcon Inc
|
$32.74B | -15.5% | +10.5% | — | 1.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AVTR | +5.0% | +6.1% | -15.1% | +6.2% | -8.3% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +5.2% | +5.2% | -22.6% | +6.3% | -17.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.